https://www.selleckchem.com/pr....oducts/cd38-inhibito
% CL 63-87%) and 11% (95% CL 6-17%). The most common grade ≥ 3 AEs were hematologic toxic effects. Conclusion In heavily treated patients, CAR-T therapy associates with promising responses and tolerable AEs, as well as CRS in RRMM. However, additional information regarding the durability of CAR-T cell therapy, as well as further randomized controlled trials, is needed.Ischemic/reperfusion (I/R) injury is the primary cause of acute kidney injury (AKI). Gastrin, a gastrointestinal hormone, is involved in the regulation of kidney
Like
Comment
Share
